n,n-dimethylarginine has been researched along with Esophageal Reflux in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cracowski, JL; Khouri, C; Revol, B; Roustit, M | 1 |
| Cooke, JP; Erlanson, DA; Ghebremariam, YT; Lee, JC; Leiper, J; LePendu, P; Shah, NH; Slaviero, A | 1 |
2 other study(ies) available for n,n-dimethylarginine and Esophageal Reflux
| Article | Year |
|---|---|
Proton pump inhibitors and Raynaud's phenomenon: is there a link?
Topics: Adverse Drug Reaction Reporting Systems; Amidohydrolases; Arginine; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Pharmacovigilance; Proton Pump Inhibitors; Raynaud Disease | 2018 |
Unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine.
Topics: Amidohydrolases; Animals; Arginine; Biomarkers; Cardiovascular Diseases; Cells, Cultured; Disease Models, Animal; Endothelium, Vascular; Esomeprazole; Gastroesophageal Reflux; Humans; Lansoprazole; Male; Mice; Mice, Inbred C57BL; Nitric Oxide Synthase Type III; Proton Pump Inhibitors; Risk Factors; Vasodilation | 2013 |